Published in EMBO J on November 01, 1993
Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J (1998) 2.07
Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. EMBO J (1994) 1.32
NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth. Mol Cell Biol (2001) 0.93
Correlation between the 1.6 A crystal structure and mutational analysis of keratinocyte growth factor. Protein Sci (1998) 0.87
A new method for predicting signal sequence cleavage sites. Nucleic Acids Res (1986) 37.19
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res (1990) 20.53
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature (1985) 10.13
The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem (1989) 5.98
Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10
Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science (1989) 4.79
Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell (1991) 4.31
Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J (1986) 4.08
Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science (1991) 3.69
Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol (1989) 3.48
Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature (1987) 3.31
Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature (1990) 3.19
Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell (1987) 3.17
Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development (1992) 2.45
Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development (1993) 2.39
Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse. EMBO J (1988) 2.08
Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci U S A (1989) 1.97
The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J (1990) 1.82
The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer. Science (1988) 1.64
Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem (1990) 1.62
Expression pattern of the FGF-related proto-oncogene int-2 suggests multiple roles in fetal development. Development (1989) 1.60
Murine mammary tumor virus (MuMTV) infection of an epithelial cell line established from C57BL/6 mouse mammary glands. Virology (1978) 1.54
Sequence organization of the human int-2 gene and its expression in teratocarcinoma cells. Oncogene (1989) 1.51
Expression of a novel FGF in the Xenopus embryo. A new candidate inducing factor for mesoderm formation and anteroposterior specification. Development (1992) 1.47
Detection and characterization of the fibroblast growth factor-related oncoprotein INT-2. Mol Cell Biol (1989) 1.21
An antisense transcript from the Xenopus laevis bFGF gene coding for an evolutionarily conserved 24 kd protein. EMBO J (1989) 1.15
The fibroblast growth factor family. Cell Growth Differ (1990) 1.15
Mesoderm induction and mesoderm-inducing factors in early amphibian development. Development (1989) 1.14
Regulation of the fibroblast growth factor receptor in early Xenopus embryos. Proc Natl Acad Sci U S A (1990) 1.12
Analysis of synthesis, processing, and secretion of proteins expressed in mammalian cells. Methods Enzymol (1990) 1.10
Biosynthesis of human fibroblast growth factor-5. Mol Cell Biol (1991) 1.09
Mesoderm-inducing properties of INT-2 and kFGF: two oncogene-encoded growth factors related to FGF. Development (1989) 1.08
Solid-phase sequence analysis of proteins electroblotted or spotted onto polyvinylidene difluoride membranes. Anal Biochem (1990) 1.05
Developmental expression of the Xenopus int-2 (FGF-3) gene: activation by mesodermal and neural induction. Development (1992) 0.98
Cell transformation by Int-2--a member of the fibroblast growth factor family. Oncogene (1991) 0.97
Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors. Cell Growth Differ (1992) 0.94
Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants. J Natl Cancer Inst (1992) 0.89
cDNA cloning and developmental expression of fibroblast growth factor receptors from Xenopus laevis. Mol Cell Biol (1991) 0.87
The structure and function of the int-2 oncogene. Prog Growth Factor Res (1989) 0.85
The Int-2/Fgf-3 oncogene product is secreted and associates with extracellular matrix: implications for cell transformation. Mol Cell Biol (1991) 0.85
Spatially restricted expression of fibroblast growth factor receptor-2 during Xenopus development. Development (1992) 0.83
Over-expression of fibroblast growth factors in Xenopus embryos. Mech Dev (1992) 0.80
The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line. Cell Growth Differ (1992) 0.78
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol (1982) 6.11
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08
Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol (1997) 5.47
Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis (1982) 5.40
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev (1995) 4.64
The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta (1998) 4.45
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development (2000) 4.33
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature (2001) 4.14
Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J (1986) 4.08
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res (1996) 3.89
Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell (1983) 3.89
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci U S A (1999) 3.77
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 3.61
Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 3.53
A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25
Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature (1990) 3.19
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15
Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis (1988) 3.09
Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet (1998) 3.03
Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis. J Virol (1977) 2.99
Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase). Proc Natl Acad Sci U S A (1975) 2.97
Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis (1997) 2.82
Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun (1986) 2.80
EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J (1994) 2.79
Intravenous cefotaxime in children with bacterial meningitis. Lancet (1980) 2.77
Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol (2001) 2.66
A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun (1997) 2.65
Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol (1998) 2.60
CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene (1994) 2.55
Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect Immun (2000) 2.54
Potential oncogene product related to growth factors. Nature (1987) 2.53
Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol (1998) 2.42
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet (1984) 2.35
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J (1995) 2.26
Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus. Nature (1986) 2.24
D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene (1991) 2.21
Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol (2001) 2.21
Prevention of osteoporosis in glucocorticoid-treated neurology patients. Clin Neurol Neurosurg (2005) 2.19
Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis (2001) 2.14
Specific binding sites in the alcR and alcA promoters of the ethanol regulon for the CREA repressor mediating carbon catabolite repression in Aspergillus nidulans. Mol Microbiol (1993) 2.13
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12
Cyclin D1 and prognosis in human breast cancer. Int J Cancer (1996) 2.11
Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun (2000) 2.11
Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature (1997) 2.10
Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun (2002) 2.08
Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse. EMBO J (1988) 2.08
Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol (1999) 2.07
Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene (1994) 1.99
Microbial colonization of prosthetic devices. III. Adhesion of staphylococci to lumina of intravenous catheters perfused with bacterial suspensions. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 1.97
Pathogenesis and management of Staphylococcus epidermidis 'plastic' foreign body infections. J Antimicrob Chemother (1984) 1.96
Microbial colonization of prosthetic devices. I. Microtopographical characteristics of intravenous catheters as detected by scanning electron microscopy. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 1.95
Morphological and biochemical characterization of viral particles produced by the tsO45 mutant of vesicular stomatitis virus at restrictive temperature. J Virol (1979) 1.93
RNA-directed DNA synthesis in Moloney murine leukemia virus: interaction between the primer tRNA and the genome RNA. J Virol (1979) 1.92
Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol (1986) 1.90
Complex structure and regulation of the P16 (MTS1) locus. Cancer Res (1995) 1.87
Protein-coding potential of mouse mammary tumor virus genome RNA as examined by in vitro translation. J Virol (1981) 1.87
The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J (1990) 1.82
Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta (1998) 1.81
Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis (1998) 1.81
Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet (2000) 1.80
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill (2014) 1.79
In vitro synthesis of polypeptides encoded by the long terminal repeat region of mouse mammary tumour virus DNA. Nature (1981) 1.77
Chromosome 11q13 abnormalities in human cancer. Cancer Cells (1991) 1.74
Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene (1990) 1.69
alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol (2001) 1.67
Multiple RNAs expressed from the int-2 gene in mouse embryonal carcinoma cell lines encode a protein with homology to fibroblast growth factors. EMBO J (1988) 1.66
A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol (1987) 1.65
Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin Infect Dis (1998) 1.64
FGF/FGFR-2(IIIb) signaling is essential for inner ear morphogenesis. J Neurosci (2000) 1.64
Mouse mammary tumor virus integration regions int-1 and int-2 map on different mouse chromosomes. Mol Cell Biol (1984) 1.64
Investigations on staphylococcal infection of transvenous endocardial pacemaker electrodes. Am Heart J (1984) 1.63
Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J Immunol (2001) 1.63
The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci U S A (1989) 1.62
The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet (1995) 1.60